Protalix BioTherapeutics (PLX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Protalix BioTherapeutics (PLX) over the last 17 years, with Q3 2025 value amounting to -$7.8 million.
- Protalix BioTherapeutics' Other Gross PP&E Adjustments fell 3835.25% to -$7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.8 million, marking a year-over-year decrease of 3835.25%. This contributed to the annual value of $34.9 million for FY2024, which is 340.13% up from last year.
- Per Protalix BioTherapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$7.8 million for Q3 2025, which was down 3835.25% from -$5.0 million recorded in Q2 2025.
- Protalix BioTherapeutics' Other Gross PP&E Adjustments' 5-year high stood at $34.9 million during Q4 2024, with a 5-year trough of -$7.8 million in Q3 2025.
- Its 5-year average for Other Gross PP&E Adjustments is $2.7 million, with a median of -$5.2 million in 2025.
- Over the last 5 years, Protalix BioTherapeutics' Other Gross PP&E Adjustments had its largest YoY gain of 1279.23% in 2025, and its largest YoY loss of 3835.25% in 2025.
- Over the past 5 years, Protalix BioTherapeutics' Other Gross PP&E Adjustments (Quarter) stood at $32.8 million in 2021, then increased by 1.22% to $33.2 million in 2022, then grew by 1.81% to $33.8 million in 2023, then grew by 3.4% to $34.9 million in 2024, then tumbled by 122.38% to -$7.8 million in 2025.
- Its last three reported values are -$7.8 million in Q3 2025, -$5.0 million for Q2 2025, and -$5.2 million during Q1 2025.